NCT05437965 National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
| NCT ID | NCT05437965 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China National Center for Cardiovascular Diseases |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2020-06-03 |
| Primary Completion | 2035-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2020-06-03 with a primary completion date of 2035-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).
Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years; 2. Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR); 3. Patients fully informed about the trial procedures who provide written informed consent. Exclusion Criteria: 1. Patients presenting with any of the following: * Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy \<12 months; * Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease; * Variant angina (Prinzmetal's angina); * Coronary artery dissection; * Thrombophilia; * Stent underexpansion. 2. Presence of psychiatric disorders; 3. Known inability to complete expected study follow-up for any reason; 4. Patients deemed ineligible for enrollment by the investigator.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05437965 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05437965 currently recruiting?
Yes, NCT05437965 is actively recruiting participants. Contact the research team at hongjian.wang@gmail.com for enrollment information.
Where is the NCT05437965 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05437965 clinical trial?
NCT05437965 is sponsored by China National Center for Cardiovascular Diseases. The trial plans to enroll 1,000 participants.